|
Yale Cancer Center NCTN
|
1U10CA180826-01
|
$551,500
|
$27,575
|
HOCHSTER, HOWARD
|
YALE UNIVERSITY
|
|
Winship Cancer Institute, National Clinical Trials Network Lead Academic Partici
|
1U10CA180864-01
|
$542,950
|
$10,859
|
RAMALINGAM, SURESH
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-06S1
|
$74,858
|
$3,743
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
5P30CA138292-06
|
$1,560,000
|
$78,000
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Washington University/ Siteman Cancer Center Lead Academic Site
|
1U10CA180833-01
|
$1,548,433
|
$77,422
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Veterans Administration hospitalization database Patient Treatment File and Outpatient Clinic File
|
ZIA CP010126 - 00580
|
$55,416
|
$2,771
|
McGlynn, Katherine
|
DCEG (NCI)
|
|
Vanderbilt Network Lead Academic Participating Site for the NCTN
|
1U10CA180847-01
|
$587,562
|
$29,378
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY
|
|
Validation and Fine-Scale Mapping of Pancreatic Cancer Susceptibility Loci
|
5R01CA154823-04
|
$564,406
|
$564,406
|
KLEIN, ALISON
|
JOHNS HOPKINS UNIVERSITY
|
|
Utilizing HuR to optimize the treatment of pancreatic cancer
|
1R21CA182692-01A1
|
$202,275
|
$202,275
|
BRODY, JONATHAN
|
THOMAS JEFFERSON UNIVERSITY
|
|
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
|
1U10CA180870-01
|
$648,000
|
$8,100
|
SCHILLER, JOAN
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP)
|
1U10CA180858-01
|
$1,192,600
|
$14,908
|
ENG, CATHY
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Using Markers to Improve Pancreatic Cancer Screening
|
5R01CA176828-02
|
$404,161
|
$404,161
|
GOGGINS, MICHAEL
|
JOHNS HOPKINS UNIVERSITY
|
|
Use of DND1 to counteract miRNA function in cancers
|
1R21CA175833-01A1
|
$208,800
|
$208,800
|
MATIN, ANGABIN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-39S1
|
$75,000
|
$750
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-39S2
|
$4,154
|
$42
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-39S3
|
$12,487
|
$125
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-39S4
|
$126,993
|
$1,270
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
5P30CA014089-39
|
$6,071,261
|
$60,713
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-28S1
|
$48,718
|
$12,180
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
UNMC Eppley Cancer Center Support Grant
|
5P30CA036727-28
|
$1,485,000
|
$371,250
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-26S1
|
$74,531
|
$3,727
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-26S2
|
$49,999
|
$2,500
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-26S3
|
$310,728
|
$15,536
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
5P30CA046592-26
|
$5,914,688
|
$295,734
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN
|
|
Understanding optimal delivery systems for cancer care
|
1R01CA174768-01A1
|
$486,648
|
$121,662
|
MILLER, DAVID
|
UNIVERSITY OF MICHIGAN
|
|
Uncover the mechanisms regulating the biogenesis and decay of miRNAs in cancer
|
ZIA BC 011566
|
$497,942
|
$49,794
|
Gu, Shuo
|
CCR (NCI)
|
|
UCSD Cancer Nanotechnology Training Center
|
5R25CA153915-05
|
$328,016
|
$82,004
|
MATTREY, ROBERT
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
UCDCCC NCTN U10 Program
|
1U10CA180846-01
|
$700,250
|
$35,013
|
GANDARA, DAVID
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
UAB / UMN SPORE in Pancreatic Cancer
|
5P50CA101955-10
|
$2,162,000
|
$2,162,000
|
BUCHSBAUM, DONALD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Tumor Microenvironment in Cancer Progression
|
ZIA BC 011332
|
$358,240
|
$35,824
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Tumor Hypoxia: Molecular Studies and Clinical Exploitation
|
5P01CA067166-17
|
$1,538,195
|
$415,313
|
GIACCIA, AMATO
|
STANFORD UNIVERSITY
|
|
Tumor expressed B7x accelerates disease and is a novel target for immunotherapy
|
1F31CA183493-01A1
|
$47,676
|
$23,838
|
OHAEGBULAM, KIM
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Triptolide Augments Death Receptor Mediated Apoptosis in Pancreatic Cancer
|
5R01CA170946-03
|
$466,751
|
$466,751
|
SALUJA, ASHOK
|
UNIVERSITY OF MINNESOTA
|
|
Translational Research in GI Cancer
|
3P50CA130810-05S1
|
$27,687
|
$16,058
|
BRENNER, DEAN
|
UNIVERSITY OF MICHIGAN
|
|
Translational Research in GI Cancer
|
5P50CA130810-05
|
$1,899,055
|
$1,101,452
|
BRENNER, DEAN
|
UNIVERSITY OF MICHIGAN
|
|
Translational Research in Cancer
|
3P30CA056036-15S1
|
$73,216
|
$4,393
|
PESTELL, RICHARD
|
THOMAS JEFFERSON UNIVERSITY
|
|
Translational Research in Cancer
|
5P30CA056036-15
|
$2,723,515
|
$163,411
|
PESTELL, RICHARD
|
THOMAS JEFFERSON UNIVERSITY
|
|
Transforming Growth Factor-Beta Signal Transduction
|
5R37CA034610-32
|
$449,103
|
$449,103
|
MASSAGUE, JOAN
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Transcriptional Coregulation in Pancreatic Adenocarcinoma Progression
|
5F30CA177123-02
|
$29,227
|
$29,227
|
FERREIRA, MARK
|
UNIVERSITY OF PENNSYLVANIA
|
|
Training Program in Molecular Oncology and Immunology
|
5T32CA009161-39
|
$716,583
|
$143,317
|
LEVY, DAVID
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Toll-like Receptor Regulation of Pancreatic Tumorigenesis
|
5R01CA168611-02
|
$341,162
|
$341,162
|
MILLER, GEORGE
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Thoracic and Gastrointestinal Oncology Branch Medical Clinical Core
|
ZID BC 011540
|
$516,926
|
$103,385
|
Hassan, Raffit
|
CCR (NCI)
|
|
Therapy of pancreatic cancer with 212Pb-labeled B7-H3 specific Ab and LDE225
|
1R21CA173120-01A1
|
$186,047
|
$186,047
|
BUCHSBAUM, DONALD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Therapeutic targeting of stratifin structure and function
|
5R01CA140582-05
|
$300,665
|
$300,665
|
ZHANG, JIAN-TING
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Therapeutic evaluation in GEM pancreatic model
|
ZIA BC 011526
|
$84,724
|
$84,724
|
Van Dyke, Terry
|
CCR (NCI)
|
|
Therapeutic Antibody Discovery from Pancreatic Cancer B Cell Repertoires
|
1R43CA189374-01A1
|
$217,469
|
$217,469
|
JOHNSON, DAVID
|
GIGAGEN, INC.
|
|
Theranostic Nano particles for Targeted Treatment of Pancreatic Cancer
|
5U01CA151810-05
|
$395,425
|
$395,425
|
YANG, LILY
|
EMORY UNIVERSITY
|
|
The Yap-Tead transcriptional complex in Kras-induced Pancreatic Ductal Adenocarci
|
1R01CA187090-01
|
$322,663
|
$322,663
|
YI, CHUNLING
|
GEORGETOWN UNIVERSITY
|
|
The Synergy Between Radiotherapy and Molecularly Targeted Agents
|
ZIA SC 010373
|
$674,875
|
$13,497
|
Camphausen, Kevin
|
CCR (NCI)
|
|
The Role of Type III TGF-beta Receptor in the Fibrotic Tumor Stroma
|
5F31CA180602-02
|
$32,882
|
$16,441
|
HESLER, RACHEL
|
DUKE UNIVERSITY
|
Total relevant funding to Pancreas for this search: $122,362,386
|